Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,843
archived clinical trials in
Prostate Cancer

A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Santa Barbara Clinical Research
mi
from
Santa Barbara, CA
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Santa Barbara Clinical Research
mi
from
Santa Barbara, CA
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
University of Colorado at Denver and Health Sciences Center
mi
from
Denver, CO
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
University of Colorado at Denver and Health Sciences Center
mi
from
Denver, CO
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
The Urology Center of Colorado
mi
from
Denver, CO
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
The Urology Center of Colorado
mi
from
Denver, CO
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Urology Associates Research
mi
from
Englewood, CO
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Urology Associates Research
mi
from
Englewood, CO
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Connecticut Clinical Research Center, LLC
mi
from
Middlebury, CT
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Connecticut Clinical Research Center, LLC
mi
from
Middlebury, CT
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Mid Michigan Medical Center
mi
from
Midland, MI
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Mid Michigan Medical Center
mi
from
Midland, MI
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Grove Hill Medical Center
mi
from
New Britain, CT
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Grove Hill Medical Center
mi
from
New Britain, CT
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Walter Reed Army Medical Center
mi
from
Washington,
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Walter Reed Army Medical Center
mi
from
Washington,
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
South Florida Medical Research
mi
from
Miami, FL
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
South Florida Medical Research
mi
from
Miami, FL
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Urology Health Solutions, Inc
mi
from
Celebration, FL
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Urology Health Solutions, Inc
mi
from
Celebration, FL
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
University of Florida Gainesville
mi
from
Gainesville, FL
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
University of Florida Gainesville
mi
from
Gainesville, FL
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Winter Park Urology Associates
mi
from
Orlando, FL
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Winter Park Urology Associates
mi
from
Orlando, FL
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Southeastern Urology Center, PA
mi
from
Tallahassee, FL
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Southeastern Urology Center, PA
mi
from
Tallahassee, FL
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Tampa Bay Urology
mi
from
Tampa, FL
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Tampa Bay Urology
mi
from
Tampa, FL
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Advanced Research Institute, Inc.
mi
from
Trinity, FL
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Advanced Research Institute, Inc.
mi
from
Trinity, FL
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Urology Enterprises
mi
from
Marietta, GA
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Urology Enterprises
mi
from
Marietta, GA
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Midwest Urology/RMD Clinical Research
mi
from
Melrose Park, IL
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Midwest Urology/RMD Clinical Research
mi
from
Melrose Park, IL
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Deaconess Billings Clinic Research Center
mi
from
Billings, MT
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Deaconess Billings Clinic Research Center
mi
from
Billings, MT
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Northeast Indiana Research
mi
from
Fort Wayne, IN
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Northeast Indiana Research
mi
from
Fort Wayne, IN
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Metropolitan Urology
mi
from
Jeffersonville, IN
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Metropolitan Urology
mi
from
Jeffersonville, IN
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
McFarland Clinic, PC
mi
from
Ames, IA
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
McFarland Clinic, PC
mi
from
Ames, IA
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Regional Urology
mi
from
Shreveport, LA
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Regional Urology
mi
from
Shreveport, LA
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Chesapeake Urology Associates
mi
from
Baltimore, MD
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Chesapeake Urology Associates
mi
from
Baltimore, MD
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Myron I Murdock MD LLC
mi
from
Greenbelt, MD
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Myron I Murdock MD LLC
mi
from
Greenbelt, MD
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Bay State Clinical Trials, Inc.
mi
from
Watertown, MA
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Bay State Clinical Trials, Inc.
mi
from
Watertown, MA
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Urological Surgical Associates
mi
from
Edison, NJ
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Urological Surgical Associates
mi
from
Edison, NJ
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Urology Associates of Englewood
mi
from
Englewood, NJ
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Urology Associates of Englewood
mi
from
Englewood, NJ
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Hamilton Urology PA
mi
from
Trenton, NJ
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Hamilton Urology PA
mi
from
Trenton, NJ
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Lyndon Baines Johnson General Hospital
mi
from
Houston, TX
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Lyndon Baines Johnson General Hospital
mi
from
Houston, TX
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Nationsmed Clinical Research
mi
from
Perth Amboy, NJ
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Nationsmed Clinical Research
mi
from
Perth Amboy, NJ
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Dell Children's Medical center
mi
from
Austin, TX
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Dell Children's Medical center
mi
from
Austin, TX
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Center for Urologic Care
mi
from
Voorhees, NJ
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Center for Urologic Care
mi
from
Voorhees, NJ
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Delaware Valley Urology LLC
mi
from
Mount Holly, NJ
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Delaware Valley Urology LLC
mi
from
Mount Holly, NJ
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Urology Group of New Mexico
mi
from
Albuquerque, NM
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Urology Group of New Mexico
mi
from
Albuquerque, NM
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
The Urological Institute of NE NY, CCP
mi
from
Albany, NY
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
The Urological Institute of NE NY, CCP
mi
from
Albany, NY
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Medical & Clinical Research Associates
mi
from
Bay Shore, NY
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Medical & Clinical Research Associates
mi
from
Bay Shore, NY
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Brooklyn Heights Urology Associates, P.C.
mi
from
Brooklyn, NY
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Brooklyn Heights Urology Associates, P.C.
mi
from
Brooklyn, NY
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
University Urology Associates
mi
from
, NY
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
University Urology Associates
mi
from
, NY
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Hudson Valley Urology
mi
from
Poughkeepsie, NY
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Hudson Valley Urology
mi
from
Poughkeepsie, NY
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Staten Island Urology Oncology
mi
from
Staten Island, NY
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Staten Island Urology Oncology
mi
from
Staten Island, NY
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Northeast Urology Research
mi
from
Concord, NC
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Northeast Urology Research
mi
from
Concord, NC
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Alliance Urology Specialists
mi
from
Greensboro, NC
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Alliance Urology Specialists
mi
from
Greensboro, NC
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Parkhurst Research Organization, LLC
mi
from
Bethany, OK
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Parkhurst Research Organization, LLC
mi
from
Bethany, OK
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Urological Associates of Lancaster
mi
from
Lancaster, PA
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Urological Associates of Lancaster
mi
from
Lancaster, PA
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
State College Urologic Association
mi
from
State College, PA
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
State College Urologic Association
mi
from
State College, PA
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Carolina Urologic Research Center
mi
from
Myrtle Beach, SC
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Carolina Urologic Research Center
mi
from
Myrtle Beach, SC
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
VA Medical Center, Lexington
mi
from
Lexington, KY
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
VA Medical Center, Lexington
mi
from
Lexington, KY
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Urology Associates
mi
from
Nashville, TN
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Urology Associates
mi
from
Nashville, TN
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Urology Associates of North Texas
mi
from
Arlington, TX
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Urology Associates of North Texas
mi
from
Arlington, TX
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Nationsmed Clinical Research
mi
from
Houston, TX
A Study of Degarelix in Patients With Prostate Cancer
A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment
Status: Archived
Updated: 1/1/1970
Nationsmed Clinical Research
mi
from
Houston, TX